Approval · Notice of Compliance 12573 · 2011
STAXYN: Notice of Compliance 12573
Issued August 18, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12573
- Date
- August 18, 2011
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Cyclic GMP-Specific Phosphodiesterase Type 5 Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STAXYN | 02372436 | Cancelled Post Market |
Medicinal ingredients
- VARDENAFIL HYDROCHLORIDE 10 MG per TAB